25. July 2026

Author: Editorial

  • >>A GENOME TALE OF 80 MILLION YEARS

    [genome sequencing] "The 22,000-year-old cave painting of an Atlantic salmon (Salmo salar) near the Vézère River in France is a reminder of our fascination with,and dependence on, Atlantic salmon throughout human history," writes researchers from Norway, Canada and Chile after concluding the great…

  • >>AQUAGEN ACQUIRES MAJORITY SHAREHOLDING OF AQUABEL

    [press release] The global salmon genetics company AquaGen has moved into fast growing tilapia breeding by acquiring a major stake in Brazilian tilapia genetic company Aquabel.

  • >>NINA SANTI NEW AQUAGEN CEO

    [press release] Nina Santi has been appointed CEO of AquaGen.

  • >>FDA CONFIRMS GMO SALMON SAFE TO EAT

    [PRESS RELEASE] The GMO salmon ready for US consumers according to FDA: AquAdvantage salmon is as safe to eat.

  • About Blue Frontier Media AS

    Blue Fronter Media AS Org. No.: 996 487 458 Adr.: Oslo Media House Skippergata 26 N-0154 Oslo Email: post@bluefrontier.media Tel.: +47 468 44 123

  • >>ZOETIS ACQUIRES PHARMAQ

    [press release] – PHARMAQ, the global leader in vaccines and innovation for health products in aquaculture, is acquired by Zoetis for a price of $765 million on a debt-free basis.

  • >>NEW SALMON BROODSTOCK FACILITY PRODUCE 100M EGGS

    [press release] Norwegian Fisheries Minister Elisabeth Aspaker inaugurated a new north Norwegian broodstock facility in Steigen, Norway, Wednesday, September, 16th, 2015.

  • >>GENETIC BREAKTROUCH IN LICE RESISTANCE

    [press release] AquaGen has discovered a QTL for lice susceptibility. By testing and selecting away brood fish with this lice-QTL, it will be possible to deliver eggs where the most lice receptive fish are removed from the population.

  • >>CARGILL ACQUIRES EWOS FOR €1.35BLN

    [press release] Minneapolis and Bergen, Norway, August 17th, 2015. Cargill has entered into an agreement with Altor Fund III and Bain Capital Europe III to acquire EWOS, a global leader in salmon nutrition for 1.35 billion euros. The transaction, which…

  • >>BENCHMARK NOK140MLN MOVE INTO TILAPIA BREEDING

    [press release] – Dual Acquisitions Advance Benchmark’s Position in Aquaculture Genetics, Making Strategic Move Into the Tilapia Genetics and Breeding Sector.